NYBC Chief Business Officer Jay Mohr and NYBC Ventures Managing Director Meg Wood (Photo: Andy Ryan Photography Inc.)

On Thursday, May 11, Wall Street Journal featured the article, “New Venture Fund Targets Innovations in Blood Research,” highlighting the work of New York Blood Center, and other healthcare nonprofits, to utilize venture capital to help startups treat diseases.

The article elaborates on NYBC’s venture fund designed to invest in startups targeting conditions that do not typically garner investor attention and details how NYBC is one of several healthcare nonprofits to form venture groups to foster innovation. As NYBCe President and CEO Christopher D. Hillyer, MD, explained, the venture team’s goal is “finding startups that not only have a humanitarian ROI, but a fiscal ROI for our blood center.”